How much did Panion & BF Biotech achieve in EBIT for the current year?
In the current year, Panion & BF Biotech has achieved an EBIT of 215.22 M TWD.
Panion & BF Biotech EBIT 2024
Panion & BF Biotech EBIT
215.22 M TWD
Ticker
1760.TW
ISIN
TW0001760007
In 2024, Panion & BF Biotech's EBIT was 215.22 M TWD, a 37.23% increase from the 156.83 M TWD EBIT recorded in the previous year.
The Panion & BF Biotech EBIT history
| YEAR | EBIT (undefined TWD) |
|---|---|
| 2024e | 215.22 |
| 2023 | 156.83 |
| 2022 | 413.96 |
| 2021 | 165.34 |
| 2020 | 104.5 |
| 2019 | 223.93 |
| 2018 | 212.54 |
| 2017 | 144.72 |
| 2016 | 129.62 |
| 2015 | 119.97 |
| 2014 | 64.4 |
| 2013 | 13.9 |
| 2012 | -47.7 |
| 2011 | -47.4 |
| 2010 | -55.4 |
| 2009 | 3.9 |
| 2008 | -50.9 |
| 2007 | 7.8 |
| 2006 | -168.2 |
| 2005 | -78.1 |
| 2004 | -28.6 |
Panion & BF Biotech Revenue, EBIT, Net Income TW0001760007 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Panion & BF Biotech, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Panion & BF Biotech from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Panion & BF Biotech’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Panion & BF Biotech. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Panion & BF Biotech’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Panion & BF Biotech’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Panion & BF Biotech’s growth potential.
Panion & BF Biotech Revenue, EBIT and net profit per share
| Date | Panion & BF Biotech Revenue | Panion & BF Biotech EBIT | Panion & BF Biotech Net Income |
|---|---|---|---|
| 2024e | 2.09 B undefined | 215.22 M undefined | 139.93 M undefined |
| 2023 | 1.88 B undefined | 156.83 M undefined | 77.22 M undefined |
| 2022 | 2.4 B undefined | 413.96 M undefined | 182.35 M undefined |
| 2021 | 1.9 B undefined | 165.34 M undefined | 104.4 M undefined |
| 2020 | 1.57 B undefined | 104.5 M undefined | 27.9 M undefined |
| 2019 | 1.57 B undefined | 223.93 M undefined | 161.33 M undefined |
| 2018 | 1.41 B undefined | 212.54 M undefined | 159.17 M undefined |
| 2017 | 1.21 B undefined | 144.72 M undefined | 90.54 M undefined |
| 2016 | 1.05 B undefined | 129.62 M undefined | 89.72 M undefined |
| 2015 | 1.21 B undefined | 119.97 M undefined | 73 M undefined |
| 2014 | 1.01 B undefined | 64.4 M undefined | 48.27 M undefined |
| 2013 | 857.1 M undefined | 13.9 M undefined | 18.1 M undefined |
| 2012 | 674.9 M undefined | -47.7 M undefined | -40.6 M undefined |
| 2011 | 584.2 M undefined | -47.4 M undefined | -36.3 M undefined |
| 2010 | 524.8 M undefined | -55.4 M undefined | -39.3 M undefined |
| 2009 | 559.4 M undefined | 3.9 M undefined | 5.1 M undefined |
| 2008 | 482.8 M undefined | -50.9 M undefined | 10.6 M undefined |
| 2007 | 545.5 M undefined | 7.8 M undefined | 3.4 M undefined |
| 2006 | 473.6 M undefined | -168.2 M undefined | -151.9 M undefined |
| 2005 | 460.9 M undefined | -78.1 M undefined | -15.1 M undefined |
| 2004 | 477 M undefined | -28.6 M undefined | -21.2 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 477 M TWD | -28.6 M TWD | -21.2 M TWD |
| 2005 | 460.9 M TWD | -78.1 M TWD | -15.1 M TWD |
| 2006 | 473.6 M TWD | -168.2 M TWD | -151.9 M TWD |
| 2007 | 545.5 M TWD | 7.8 M TWD | 3.4 M TWD |
| 2008 | 482.8 M TWD | -50.9 M TWD | 10.6 M TWD |
| 2009 | 559.4 M TWD | 3.9 M TWD | 5.1 M TWD |
| 2010 | 524.8 M TWD | -55.4 M TWD | -39.3 M TWD |
| 2011 | 584.2 M TWD | -47.4 M TWD | -36.3 M TWD |
| 2012 | 674.9 M TWD | -47.7 M TWD | -40.6 M TWD |
| 2013 | 857.1 M TWD | 13.9 M TWD | 18.1 M TWD |
| 2014 | 1.01 B TWD | 64.4 M TWD | 48.27 M TWD |
| 2015 | 1.21 B TWD | 119.97 M TWD | 73 M TWD |
| 2016 | 1.05 B TWD | 129.62 M TWD | 89.72 M TWD |
| 2017 | 1.21 B TWD | 144.72 M TWD | 90.54 M TWD |
| 2018 | 1.41 B TWD | 212.54 M TWD | 159.17 M TWD |
| 2019 | 1.57 B TWD | 223.93 M TWD | 161.33 M TWD |
| 2020 | 1.57 B TWD | 104.5 M TWD | 27.9 M TWD |
| 2021 | 1.9 B TWD | 165.34 M TWD | 104.4 M TWD |
| 2022 | 2.4 B TWD | 413.96 M TWD | 182.35 M TWD |
| 2023 | 1.88 B TWD | 156.83 M TWD | 77.22 M TWD |
| 2024e | 2.09 B TWD | 215.22 M TWD | 139.93 M TWD |
Panion & BF Biotech stock margins TW0001760007 ·
The Panion & BF Biotech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Panion & BF Biotech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Panion & BF Biotech.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Panion & BF Biotech's sales revenue. A higher gross margin percentage indicates that the Panion & BF Biotech retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Panion & BF Biotech's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Panion & BF Biotech's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Panion & BF Biotech's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Panion & BF Biotech. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Panion & BF Biotech's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Panion & BF Biotech Margin History
| Panion & BF Biotech Gross margin | Panion & BF Biotech Profit margin | Panion & BF Biotech EBIT margin | Panion & BF Biotech Profit margin |
|---|---|---|---|
| 2024e | 51.78 % | 10.31 % | 6.7 % |
| 2023 | 51.78 % | 8.33 % | 4.1 % |
| 2022 | 54.97 % | 17.26 % | 7.6 % |
| 2021 | 47.98 % | 8.7 % | 5.49 % |
| 2020 | 51.89 % | 6.66 % | 1.78 % |
| 2019 | 54.91 % | 14.23 % | 10.25 % |
| 2018 | 57.03 % | 15.09 % | 11.3 % |
| 2017 | 57.27 % | 11.94 % | 7.47 % |
| 2016 | 56.09 % | 12.35 % | 8.55 % |
| 2015 | 61.07 % | 9.96 % | 6.06 % |
| 2014 | 60.04 % | 6.35 % | 4.76 % |
| 2013 | 54.23 % | 1.62 % | 2.11 % |
| 2012 | 51.55 % | -7.07 % | -6.02 % |
| 2011 | 51.64 % | -8.11 % | -6.21 % |
| 2010 | 56 % | -10.56 % | -7.49 % |
| 2009 | 53.13 % | 0.7 % | 0.91 % |
| 2008 | 49.61 % | -10.54 % | 2.2 % |
| 2007 | 53.73 % | 1.43 % | 0.62 % |
| 2006 | 44.51 % | -35.52 % | -32.07 % |
| 2005 | 49.4 % | -16.95 % | -3.28 % |
| 2004 | 53.67 % | -6 % | -4.44 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 53.67 % | -6 % | -4.44 % |
| 2005 | 49.4 % | -16.95 % | -3.28 % |
| 2006 | 44.51 % | -35.52 % | -32.07 % |
| 2007 | 53.73 % | 1.43 % | 0.62 % |
| 2008 | 49.61 % | -10.54 % | 2.2 % |
| 2009 | 53.13 % | 0.7 % | 0.91 % |
| 2010 | 56 % | -10.56 % | -7.49 % |
| 2011 | 51.64 % | -8.11 % | -6.21 % |
| 2012 | 51.55 % | -7.07 % | -6.02 % |
| 2013 | 54.23 % | 1.62 % | 2.11 % |
| 2014 | 60.04 % | 6.35 % | 4.76 % |
| 2015 | 61.07 % | 9.96 % | 6.06 % |
| 2016 | 56.09 % | 12.35 % | 8.55 % |
| 2017 | 57.27 % | 11.94 % | 7.47 % |
| 2018 | 57.03 % | 15.09 % | 11.3 % |
| 2019 | 54.91 % | 14.23 % | 10.25 % |
| 2020 | 51.89 % | 6.66 % | 1.78 % |
| 2021 | 47.98 % | 8.7 % | 5.49 % |
| 2022 | 54.97 % | 17.26 % | 7.6 % |
| 2023 | 51.78 % | 8.33 % | 4.1 % |
| 2024e | 51.78 % | 10.31 % | 6.7 % |
Panion & BF Biotech Aktienanalyse
What does Panion & BF Biotech do?
Panion & BF Biotech Inc. is a Canadian company in the field of biotechnology. The company was founded in 2011 and has its headquarters in Vancouver, British Columbia. Panion & BF Biotech Inc. is listed on the Korean Stock Exchange and has offices in Korea and Hong Kong. The history of Panion & BF Biotech Inc. began when the company was founded by a group of experts in the field of biotechnology to develop innovative solutions that promote animal health and improve agricultural production. In recent years, the company has expanded its activities into various sectors and now offers a wide range of products and services tailored to the needs of animal owners and farmers. The business model of Panion & BF Biotech Inc. is based on the development and marketing of biotechnology products for animal health and agricultural production. The company also conducts research and development of new technologies and products aimed at increasing the efficiency of farmers and animal owners. Panion & BF Biotech Inc. works closely with universities and other research institutions to develop new product ideas. The company has various divisions, including the production of animal medicines, microorganisms, probiotics, and prebiotics, feed additives such as enzyme preparations, and urinary tract infection (UTI) tests. Panion & BF Biotech Inc. is also involved in the development of technologies such as gene editing and CRISPR/Cas9. The company also develops solutions to combat antibiotic resistance in livestock. In recent years, the company has developed and launched a number of products. One of these products is Aivlosin, an animal medicine used to treat respiratory diseases and infections in pigs and chickens. Aivlosin is also approved in North America and Europe. Another product from Panion & BF Biotech Inc. is the probiotic Smaart, which can improve the intestinal health of pigs and chickens. Panion & BF Biotech Inc. works closely with animal owners and farmers to understand their needs and develop products and services that help them overcome their challenges. The company has a broad customer base in various regions of the world, including North America, Europe, and Asia. Overall, Panion & BF Biotech Inc. has become a major player in the biotechnology industry. The company specializes in developing products that promote animal health and improve agricultural production. Panion & BF Biotech Inc. is committed to further investing in research and development of new technologies to meet the needs of animal owners and farmers. Panion & BF Biotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Panion & BF Biotech's EBIT
Panion & BF Biotech's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Panion & BF Biotech's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Panion & BF Biotech's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Panion & BF Biotech’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Panion & BF Biotech stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Panion & BF Biotech.
How has the EBIT of Panion & BF Biotech developed in recent years?
The EBIT of Panion & BF Biotech has increased by 37.232% increased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Panion & BF Biotech?
The EBIT of Panion & BF Biotech is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Panion & BF Biotech pay?
Over the past 12 months, Panion & BF Biotech paid a dividend of 2 TWD . This corresponds to a dividend yield of about 2.02 %. For the coming 12 months, Panion & BF Biotech is expected to pay a dividend of 2 TWD.
What is the dividend yield of Panion & BF Biotech?
The current dividend yield of Panion & BF Biotech is 2.02 %.
When does Panion & BF Biotech pay dividends?
Panion & BF Biotech pays a quarterly dividend. This is distributed in the months of July, July, August, July.
How secure is the dividend of Panion & BF Biotech?
Panion & BF Biotech paid dividends every year for the past 10 years.
What is the dividend of Panion & BF Biotech?
For the upcoming 12 months, dividends amounting to 2 TWD are expected. This corresponds to a dividend yield of 2.02 %.
In which sector is Panion & BF Biotech located?
Panion & BF Biotech is assigned to the 'Health' sector.
Wann musste ich die Aktien von Panion & BF Biotech kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Panion & BF Biotech from 7/10/2024 amounting to 1.5 TWD, you needed to have the stock in your portfolio before the ex-date on 6/13/2024.
When did Panion & BF Biotech pay the last dividend?
The last dividend was paid out on 7/10/2024.
What was the dividend of Panion & BF Biotech in the year 2023?
In the year 2023, Panion & BF Biotech distributed 1.5 TWD as dividends.
In which currency does Panion & BF Biotech pay out the dividend?
The dividends of Panion & BF Biotech are distributed in TWD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Panion & BF Biotech
Our stock analysis for Panion & BF Biotech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Panion & BF Biotech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Panion & BF Biotech Revenue
- Panion & BF Biotech Net Income
- Panion & BF Biotech P/E
- Panion & BF Biotech P/S
- Panion & BF Biotech EBIT
- Panion & BF Biotech Dividend
- Panion & BF Biotech Stocks
- Panion & BF Biotech Market capitalization
- Panion & BF Biotech Debt
- Panion & BF Biotech Liabilities
- Panion & BF Biotech Equity
- Panion & BF Biotech AAQS
- Panion & BF Biotech Employees
- Panion & BF Biotech ROE
- Panion & BF Biotech ROA
- Panion & BF Biotech ROCE